Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agents
Introduction: Hepatitis C (HCV) is associated with extra-hepatic involvment, morbidity as well as metabolic changes. Whether these might be reversible if sustained virologic response (SVR) is achieved by direct-acting antiviral (DAA) therapy remains unknown. Methods: Chronic hepatitis C (CHC) indivi...
Main Authors: | Pin-Nan Cheng, Hung-Yu Sun, I-Che Feng, Sin-Tian Wang, Yen-Cheng Chiu, Hung-Chih Chiu, Shih-Chieh Chien, Kung-Chia Young |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Journal of Virus Eradication |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664023000043 |
Similar Items
-
Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
by: Chen-Ta Chi, et al.
Published: (2021-06-01) -
Evaluation of long-term changes of aspartate—platelet ratio index, FIB4, and liver stiffness in chronic hepatitis C patients successfully treated by direct-acting antivirals
by: Nadia Abdel Ataay Abdelkader, et al.
Published: (2021-08-01) -
Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents
by: Pin-Nan Cheng, et al.
Published: (2023-02-01) -
Real-Life Data of Chronic Hepatitis C Patients Treated with Direct-Acting Oral Antivirals: A Single-Center Study
by: Umut Devrim Binay, et al.
Published: (2023-05-01) -
Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
by: Inas E L-Khedr Mohamed, et al.
Published: (2021-04-01)